1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Hu, H.T. Chazin, W.J. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking UK J.Mol.Biol. JMOBAK 0070 0022-2836 330 473 484 10.1016/S0022-2836(03)00619-3 12842464 Unique Features in the C-terminal Domain Provide Caltractin with Target Specificity 2003 10.2210/pdb1oqp/pdb pdb_00001oqp 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1 SINGLE WAVELENGTH M 1 1.0 8977.838 Caltractin 1 man polymer 2501.003 Cell division control protein KAR1 1 syn polymer Centrin, 20 kDa calcium-binding protein no no GSGERDSREEILKAFRLFDDDNSGTITIKDLRRVAKELGENLTEEELQEMIAEADRNDDNEIDEDEFIRIMKKTSLF GSGERDSREEILKAFRLFDDDNSGTITIKDLRRVAKELGENLTEEELQEMIAEADRNDDNEIDEDEFIRIMKKTSLF A polypeptide(L) no no KKRELIESKWHRLLFHDKK KKRELIESKWHRLLFHDKK B polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n Chlamydomonas Escherichia sample 3055 Chlamydomonas reinhardtii 562 Escherichia coli BL21(DE3)PlysS Plasmid PET database_2 pdbx_nmr_software pdbx_struct_assembly pdbx_struct_oper_list struct_ref_seq_dif repository Initial release Version format compliance Version format compliance Data collection Database references Derived calculations 1 0 2003-06-24 1 1 2008-04-29 1 2 2011-07-13 1 3 2022-02-23 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_nmr_software.name _struct_ref_seq_dif.details RCSB Y RCSB 2003-03-10 REL REL The peptide consists of the cdc31p-binding domain from Kar1p, residues 239-257, and has been chemically synthesized using solid phase F-Moc chemistry. The sequence is naturally found in Saccharomyces cerevisiae (baker's yeast). sample structures with the least restraint violations,structures with the lowest energy 60 20 3D_15N-separated_NOESY 3D_13C-separated_NOESY 4D_13C-separated_NOESY 2D NOESY 3D 13C-F1-edited, 13C-F3-filtered NOESY 50mM KCl, 5mM CaCl2 7.0 ambient 298 K the structures are based on a total of 1827 constraints, 1641 are NOE-derived distance constraints, 134 dihedral angle constraints, 52 distance constraints from hydrogen bonds. torsion angle dynamics 1mM CRC-C U-15N,13C; 1.2mM K19 unlabeled. 5mM CaCl2, 25mM Tris, 50mM KCl, 90% H2O, 10% D2O 1mM CRC-C U-15N,13C; 1.2mM K19 unlabeled. 5mM CaCl2, 25mM Tris, 50mM KCl, 100% D2O 1mM CRC-C unlabeled; 1.2 mM K19 unlabeled. 5mM CaCl2, 25mM Tris, 50mM KCl, 90% H2O, 10% D2O Bruker collection XwinNMR 2.6 Accelrys, San Diego, CA processing Felix 2000 Accelrys, San Diego, CA data analysis Felix 2000 Guntert, P., Mumenthaler, C. & Wuthrich, K. structure solution DYANA 1.5 Pearlman, D.A., Case, D.A., Caldwell, J.W., Ross, W.S., Cheatham III, T.E., DeBolt, S., Ferguson, D., Seibel, G., Kollman, P. refinement Amber 7.0 600 Bruker DRX 800 Bruker DRX GLY 93 n 1 GLY 93 A SER 94 n 2 SER 94 A GLY 95 n 3 GLY 95 A GLU 96 n 4 GLU 96 A ARG 97 n 5 ARG 97 A ASP 98 n 6 ASP 98 A SER 99 n 7 SER 99 A ARG 100 n 8 ARG 100 A GLU 101 n 9 GLU 101 A GLU 102 n 10 GLU 102 A ILE 103 n 11 ILE 103 A LEU 104 n 12 LEU 104 A LYS 105 n 13 LYS 105 A ALA 106 n 14 ALA 106 A PHE 107 n 15 PHE 107 A ARG 108 n 16 ARG 108 A LEU 109 n 17 LEU 109 A PHE 110 n 18 PHE 110 A ASP 111 n 19 ASP 111 A ASP 112 n 20 ASP 112 A ASP 113 n 21 ASP 113 A ASN 114 n 22 ASN 114 A SER 115 n 23 SER 115 A GLY 116 n 24 GLY 116 A THR 117 n 25 THR 117 A ILE 118 n 26 ILE 118 A THR 119 n 27 THR 119 A ILE 120 n 28 ILE 120 A LYS 121 n 29 LYS 121 A ASP 122 n 30 ASP 122 A LEU 123 n 31 LEU 123 A ARG 124 n 32 ARG 124 A ARG 125 n 33 ARG 125 A VAL 126 n 34 VAL 126 A ALA 127 n 35 ALA 127 A LYS 128 n 36 LYS 128 A GLU 129 n 37 GLU 129 A LEU 130 n 38 LEU 130 A GLY 131 n 39 GLY 131 A GLU 132 n 40 GLU 132 A ASN 133 n 41 ASN 133 A LEU 134 n 42 LEU 134 A THR 135 n 43 THR 135 A GLU 136 n 44 GLU 136 A GLU 137 n 45 GLU 137 A GLU 138 n 46 GLU 138 A LEU 139 n 47 LEU 139 A GLN 140 n 48 GLN 140 A GLU 141 n 49 GLU 141 A MET 142 n 50 MET 142 A ILE 143 n 51 ILE 143 A ALA 144 n 52 ALA 144 A GLU 145 n 53 GLU 145 A ALA 146 n 54 ALA 146 A ASP 147 n 55 ASP 147 A ARG 148 n 56 ARG 148 A ASN 149 n 57 ASN 149 A ASP 150 n 58 ASP 150 A ASP 151 n 59 ASP 151 A ASN 152 n 60 ASN 152 A GLU 153 n 61 GLU 153 A ILE 154 n 62 ILE 154 A ASP 155 n 63 ASP 155 A GLU 156 n 64 GLU 156 A ASP 157 n 65 ASP 157 A GLU 158 n 66 GLU 158 A PHE 159 n 67 PHE 159 A ILE 160 n 68 ILE 160 A ARG 161 n 69 ARG 161 A ILE 162 n 70 ILE 162 A MET 163 n 71 MET 163 A LYS 164 n 72 LYS 164 A LYS 165 n 73 LYS 165 A THR 166 n 74 THR 166 A SER 167 n 75 SER 167 A LEU 168 n 76 LEU 168 A PHE 169 n 77 PHE 169 A LYS 239 n 1 LYS 239 B LYS 240 n 2 LYS 240 B ARG 241 n 3 ARG 241 B GLU 242 n 4 GLU 242 B LEU 243 n 5 LEU 243 B ILE 244 n 6 ILE 244 B GLU 245 n 7 GLU 245 B SER 246 n 8 SER 246 B LYS 247 n 9 LYS 247 B TRP 248 n 10 TRP 248 B HIS 249 n 11 HIS 249 B ARG 250 n 12 ARG 250 B LEU 251 n 13 LEU 251 B LEU 252 n 14 LEU 252 B PHE 253 n 15 PHE 253 B HIS 254 n 16 HIS 254 B ASP 255 n 17 ASP 255 B LYS 256 n 18 LYS 256 B LYS 257 n 19 LYS 257 B author_defined_assembly 2 dimeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A N ILE 118 A N ILE 26 A O ILE 154 A O ILE 62 1 A ARG 124 0.099 SIDE CHAIN 1 B ARG 241 0.089 SIDE CHAIN 3 B ARG 250 0.085 SIDE CHAIN 4 A ARG 125 0.084 SIDE CHAIN 6 A ARG 124 0.090 SIDE CHAIN 6 B HIS 249 0.095 SIDE CHAIN 7 B HIS 249 0.080 SIDE CHAIN 8 A ARG 125 0.082 SIDE CHAIN 8 B ARG 241 0.103 SIDE CHAIN 10 A ARG 124 0.095 SIDE CHAIN 12 B PHE 253 0.082 SIDE CHAIN 13 A ARG 97 0.131 SIDE CHAIN 13 A ARG 124 0.103 SIDE CHAIN 16 B HIS 249 0.107 SIDE CHAIN 17 A ARG 125 0.082 SIDE CHAIN 19 B HIS 249 0.082 SIDE CHAIN 3 -3.33 0.50 120.30 116.97 B B B NE CZ NH2 ARG ARG ARG 241 241 241 N 1 B PHE 253 -77.66 37.82 1 B ASP 255 -67.89 79.10 1 B LYS 256 66.49 -70.63 2 A ASP 98 43.92 -137.11 2 A ASN 149 172.13 -57.33 2 A ASP 150 79.60 57.00 2 A ASN 152 75.57 -8.69 2 B GLU 242 -29.56 -52.28 3 A GLU 132 -66.58 92.07 3 B HIS 254 -170.11 -47.41 3 B ASP 255 46.29 -139.52 3 B LYS 256 69.09 -62.72 4 A ASP 98 36.95 -135.48 4 A ASP 150 74.59 42.72 4 A ASN 152 76.44 -3.71 4 B GLU 242 -103.56 -89.17 4 B PHE 253 -75.66 36.14 4 B LYS 256 -69.17 72.80 5 A ASP 150 76.02 38.01 5 A ASN 152 71.21 32.82 6 A ASP 150 75.91 33.14 7 A SER 94 69.91 -60.43 7 A GLU 96 -67.54 93.94 7 A ASP 98 -115.14 -75.52 7 A ASP 150 59.26 15.13 7 A ASN 152 83.70 -15.35 7 B HIS 254 33.44 -112.98 8 A SER 99 -27.82 -42.13 8 A GLU 132 -66.22 91.28 8 A ASN 149 165.51 -49.72 8 A ASP 150 74.45 59.39 8 B LYS 240 74.54 -40.64 8 B ASP 255 -175.56 -124.06 9 A SER 94 -71.08 -72.92 9 A ASP 98 -151.36 -68.39 9 A GLU 132 -62.86 90.82 9 A ASN 149 175.62 -109.99 9 A ASP 150 -172.64 27.05 9 B ARG 241 96.54 103.63 10 A SER 94 -75.38 49.70 10 A GLU 132 -60.00 97.56 10 A ASP 150 74.67 35.37 10 B ARG 241 -172.06 -44.60 11 A SER 94 -73.40 40.35 11 A ASN 152 85.65 -5.10 12 A SER 99 71.12 -56.43 12 A ASP 150 29.62 51.23 12 A ASN 152 79.63 -15.70 12 B LEU 252 -93.73 -72.99 12 B LYS 256 66.79 -65.66 13 A ARG 97 -69.59 72.16 13 A ASP 150 84.39 13.95 13 B LYS 240 41.12 -98.59 14 A ASN 152 83.86 -8.94 14 B ARG 241 67.62 -68.55 14 B PHE 253 -74.00 34.34 14 B ASP 255 69.08 -58.02 14 B LYS 256 -68.47 75.56 15 A ARG 97 -76.73 41.85 15 A ASP 98 -102.09 -63.50 15 A ASN 152 109.85 26.41 15 B ARG 241 70.44 -58.72 15 B PHE 253 -85.30 38.22 15 B ASP 255 65.56 166.27 16 A SER 94 -65.38 67.32 16 A ASN 114 54.34 17.98 16 A ASN 152 70.68 34.05 17 A SER 94 -12.02 -76.03 17 A ARG 97 -78.37 49.91 17 A SER 115 -76.57 32.74 17 A ALA 146 -101.03 -60.57 17 A ASP 147 -58.20 103.41 17 A ASN 152 103.10 17.80 18 A SER 94 59.91 -152.73 18 A ASP 150 75.55 38.18 18 B PHE 253 -74.25 46.12 18 B HIS 254 -164.57 88.41 20 A GLU 132 -65.20 92.46 20 A ASP 150 82.89 29.09 20 B HIS 254 19.58 73.28 20 B LYS 256 -68.83 80.20 STRUCTURE OF THE CA2+/C-TERMINAL DOMAIN OF CALTRACTIN IN COMPLEX WITH THE CDC31P-BINDING DOMAIN FROM KAR1P 1 N N 2 N N A ASP 98 A ASP 6 HELX_P A ASP 111 A ASP 19 1 1 14 A ILE 120 A ILE 28 HELX_P A GLY 131 A GLY 39 1 2 12 A THR 135 A THR 43 HELX_P A ASP 147 A ASP 55 1 3 13 A ASP 155 A ASP 63 HELX_P A THR 166 A THR 74 1 4 12 B LYS 239 B LYS 1 HELX_P B PHE 253 B PHE 15 1 5 15 PROTEIN BINDING protein-peptide complex, caltractin, KAR1P, calcium-binding, PROTEIN BINDING CATR_CHLRE UNP 1 95 P05434 GERDSREEILKAFRLFDDDNSGTITIKDLRRVAKELGENLTEEELQEMIAEADRNDDNEIDEDEFIRIMKKTSLF KAR1_YEAST UNP 2 239 P11927 KKRELIESKWHRLLFHDKK 95 169 1OQP 95 169 P05434 A 1 3 77 239 257 1OQP 239 257 P11927 B 2 1 19 1 expression tag GLY 93 1OQP A P05434 UNP 1 1 expression tag SER 94 1OQP A P05434 UNP 2 2 anti-parallel A ILE 118 A ILE 26 A THR 119 A THR 27 A GLU 153 A GLU 61 A ILE 154 A ILE 62